Shandong Cancer Hospital And Institute
Clinical trials sponsored by Shandong Cancer Hospital And Institute, explained in plain language.
-
New combo therapy aims to control Hard-to-Treat pancreatic cancer
Disease control Not yet recruitingThis study tests a combination of targeted radiation (SBRT) and a chemotherapy regimen called NALIRIFOX in 42 adults with locally advanced pancreatic cancer that cannot be removed by surgery. The goal is to see if this approach can delay cancer growth and improve survival. Partic…
Phase: PHASE2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New study aims to personalize breast cancer treatment by analyzing tumor subtypes
Disease control Not yet recruitingThis study looks at over 1,000 people with HER2-positive breast cancer to see how their tumor's molecular makeup affects response to a standard pre-surgery drug combination (trastuzumab, pertuzumab, and chemotherapy). The goal is to find which subtypes respond best, helping docto…
Phase: NA • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated May 14, 2026 12:02 UTC